First-in-Class Oral Semaglutide: Overcoming Barriers of Incretinisation in the Indian Context.
首創口服 Semaglutide:克服印度情境中胰高血糖素化的障礙。
Indian J Endocrinol Metab 2023-10-31
Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy.
腸道荷爾蒙基藥理學:新型配方及未來代謝疾病治療的可能性。
Diabetologia 2023-09-15
A review of recent research and development on GLP-1 receptor agonists-sustained-release microspheres.
GLP-1 受體激動劑持續釋放微球的最新研究和發展綜述。
J Mater Chem B 2024-01-09
New insights into nanomedicines for oral delivery of glucagon-like peptide-1 analogs.
口服胰高血糖素樣肽類藥物的奈米藥物在傳遞上的新見解。
Wiley Interdiscip Rev Nanomed Nanobiotechnol 2024-03-20
Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now?
口服胰高血糖素樣肽-1受體激動劑及腸胰激素組合物作為治療成人2型糖尿病的現況何在?
Expert Opin Pharmacother 2024-05-22